Clinical Trial

Transcutaneous Auricular Vagus Nerve Stimulation Treatment for Rosacea

Recruiting
View on ClinicalTrials.gov →
Summary
A single arm, pilot study among individuals with rosacea and at least moderate flushing or rednesss will be enrolled in a 4-week trial of taVNS. The particicpants will be followed for an additional 4-weeks following the intervention period to evaluate the durability of the results
Protocol Amendment History 1 change
critical Recruitment opened 2026-08-15
Trial Details
NCT Number NCT07600424
Lead Sponsor Brigham and Women's Hospital
Conditions Rosacea, Rosacea, Erythematotelangiectatic, Flushing
Enrollment 10 participants
Start Date 2026-05-23
Primary Completion 2027-12-31 (estimated)
Study Completion 2028-02-28 (estimated)
Updated on ClinicalTrials.gov 2026-08-14